Growth factor independent-1 Maintains Notch1-Dependent Transcriptional Programming of Lymphoid Precursors

PLoS Genetics

Volumn 9, Issue 9, 2013, Pages

  Phelan, James D ^a,e   Saba, Ingrid ^b,c,e   Zeng, Hui ^d   Kosan, Christian ^b,f   Messer, Malynda S ^a   Olsson, H Andre ^a   Fraszczak, Jennifer ^b   Hildeman, David A ^a   Aronow, Bruce J ^a   Möröy, Tarik ^b,c   Grimes, H Leighton ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e NATIONAL CANCER INSTITUTE   (United States)

^f FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR INDEPENDENT 1; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LOSS; CONTROLLED STUDY; DEVELOPMENT; EARLY T LINEAGE PROGENITOR; FLT3 GENE; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; IL7R GENE; LETHALITY; LYMPHOCYTE TRANSFORMATION; LYMPHOID PRIMED MULTIPOTENT PROGENITOR; LYMPHOID PROGENITOR CELL; LYMPHOPOIESIS; MOUSE; NONHUMAN; NOTCH1 GENE; NUCLEOTIDE SEQUENCE; RAG1 GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; CELL LINEAGE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REGULATORY NETWORKS; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTES; MICE; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 84884694957     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003713     Document Type: Article

References (76)

1. Gilks CB, Bear SE, Grimes HL, Tsichlis PN, (1993) Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol 13: 1759-1768.
2. Uren AG, Kool J, Matentzoglu K, de Ridder J, Mattison J, et al. (2008) Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133: 727-741.
3. Grimes HL, Chan TO, Zweidler-McKay PA, Tong B, Tsichlis PN, (1996) The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol 16: 6263-6272.
4. Zweidler-Mckay PA, Grimes HL, Flubacher MM, Tsichlis PN, (1996) Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol 16: 4024-4034.
5. Zarebski A, Velu CS, Baktula AM, Bourdeau T, Horman SR, et al. (2008) Mutations in growth factor independent-1 associated with human neutropenia block murine granulopoiesis through colony stimulating factor-1. Immunity 28: 370-380.
6. Karsunky H, Zeng H, Schmidt T, Zevnik B, Kluge R, et al. (2002) Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet 30: 295-300.
7. Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, et al. (2004) Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431: 1002-1007.
8. Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T, (2004) Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J 23: 4116-4125.
9. Yucel R, Karsunky H, Klein-Hitpass L, Moroy T, (2003) The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med 197: 831-844.
10. Zhu J, Jankovic D, Grinberg A, Guo L, Paul WE, (2006) Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion. Proc Natl Acad Sci U S A 103: 18214-18219.
11. Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, et al. (1999) Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10: 547-558.
12. Hadland BK, Manley NR, Su D, Longmore GD, Moore CL, et al. (2001) Gamma-secretase inhibitors repress thymocyte development. Proc Natl Acad Sci U S A 98: 7487-7491.
13. Wilson A, MacDonald HR, Radtke F, (2001) Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med 194: 1003-1012.
14. Han H, Tanigaki K, Yamamoto N, Kuroda K, Yoshimoto M, et al. (2002) Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int Immunol 14: 637-645.
15. Maillard I, Weng AP, Carpenter AC, Rodriguez CG, Sai H, et al. (2004) Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood 104: 1696-1702.
16. Anderson G, Pongracz J, Parnell S, Jenkinson EJ, (2001) Notch ligand-bearing thymic epithelial cells initiate and sustain Notch signaling in thymocytes independently of T cell receptor signaling. Eur J Immunol 31: 3349-3354.
17. Schmitt TM, Zuniga-Pflucker JC, (2002) Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17: 749-756.
18. Lehar SM, Dooley J, Farr AG, Bevan MJ, (2005) Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors. Blood 105: 1440-1447.
19. Kopan R, Schroeter EH, Weintraub H, Nye JS, (1996) Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci U S A 93: 1683-1688.
20. Schroeter EH, Kisslinger JA, Kopan R, (1998) Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393: 382-386.
21. Struhl G, Adachi A, (1998) Nuclear access and action of notch in vivo. Cell 93: 649-660.
22. Rothenberg EV, Zhang J, Li L, (2010) Multilayered specification of the T-cell lineage fate. Immunol Rev 238: 150-168.
23. Maillard I, Koch U, Dumortier A, Shestova O, Xu L, et al. (2008) Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell 2: 356-366.
24. Chiang MY, Shestova O, Xu L, Aster JC, Pear WS, (2012) Divergent effects of supraphysiological Notch signals on leukemia stem cells and hematopoietic stem cells. Blood 121 (6) (): 905-17.
25. Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, et al. (2011) A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 473: 230-233.
26. Sambandam A, Maillard I, Zediak VP, Xu L, Gerstein RM, et al. (2005) Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol 6: 663-670.
27. Pui CH, (2000) Acute lymphoblastic leukemia in children. Curr Opin Oncol 12: 3-12.
28. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, et al. (1991) TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66: 649-661.
29. Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, et al. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306: 269-271.
30. Sulis ML, O W, Tosello V, Pallippukam S, Palomero T, et al. (2007) A Novel Class of Acitvating Mutations in NOTCH1 in T-ALL. Blood 110: 213a.
31. Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, et al. (2007) The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 204: 1825-1835.
32. De Keersmaecker K, Atak ZK, Li N, Vicente C, Patchett S, et al. (2013) Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet 45: 186-190.
33. Malecki MJ, Sanchez-Irizarry C, Mitchell JL, Histen G, Xu ML, et al. (2006) Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol 26: 4642-4651.
34. Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, et al. (2012) The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481: 157-163.
35. Zornig M, Schmidt T, Karsunky H, Grzeschiczek A, Moroy T, (1996) Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene 12: 1789-1801.
36. Schmidt T, Karsunky H, Gau E, Zevnik B, Elsasser HP, et al. (1998) Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene 17: 2661-2667.
37. Khandanpour C, Phelan JD, Vassen L, Schutte J, Chen R, et al. (2013) Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia. Cancer Cell 23: 200-214.
38. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, et al. (2001) A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15: 763-774.
39. Murtaugh LC, Stanger BZ, Kwan KM, Melton DA, (2003) Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci U S A 100: 14920-14925.
40. Robey E, Chang D, Itano A, Cado D, Alexander H, et al. (1996) An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 87: 483-492.
41. Allman D, Karnell FG, Punt JA, Bakkour S, Xu L, et al. (2001) Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J Exp Med 194: 99-106.
42. Li X, Gounari F, Protopopov A, Khazaie K, von Boehmer H, (2008) Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J Exp Med 205: 2851-2861.
43. Tanigaki K, Tsuji M, Yamamoto N, Han H, Tsukada J, et al. (2004) Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity 20: 611-622.
44. Wolfer A, Bakker T, Wilson A, Nicolas M, Ioannidis V, et al. (2001) Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol 2: 235-241.
45. Zhang DJ, Wang Q, Wei J, Baimukanova G, Buchholz F, et al. (2005) Selective expression of the Cre recombinase in late-stage thymocytes using the distal promoter of the Lck gene. J Immunol 174: 6725-6731.
46. Horman SR, Velu CS, Chaubey A, Bourdeau T, Zhu J, et al. (2009) Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood 113: 5466-5475.
47. Espinosa L, Cathelin S, D'Altri T, Trimarchi T, Statnikov A, et al. (2010) The Notch/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia. Cancer Cell 18: 268-281.
48. Zhang JA, Mortazavi A, Williams BA, Wold BJ, Rothenberg EV, (2012) Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity. Cell 149: 467-482.
49. Luc S, Luis TC, Boukarabila H, Macaulay IC, Buza-Vidas N, et al. (2012) The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential. Nat Immunol 13 (4) (): 412-9.
50. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
51. Chen J, Bardes EE, Aronow BJ, Jegga AG, (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37: W305-311.
52. Lai AY, Kondo M, (2007) Identification of a bone marrow precursor of the earliest thymocytes in adult mouse. Proc Natl Acad Sci U S A 104: 6311-6316.
53. Zhuang D, Qiu Y, Kogan SC, Dong F, (2006) Increased CCAAT enhancer-binding protein epsilon (C/EBPepsilon) expression and premature apoptosis in myeloid cells expressing Gfi-1 N382S mutant associated with severe congenital neutropenia. J Biol Chem 281: 10745-10751.
54. Ordonez-Rueda D, Jonsson F, Mancardi DA, Zhao W, Malzac A, et al. (2012) A hypomorphic mutation in the Gfi1 transcriptional repressor results in a novel form of neutropenia. Eur J Immunol 42: 2395-2408.
55. Yucel R, Kosan C, Heyd F, Moroy T, (2004) Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development. J Biol Chem 279: 40906-40917.
56. Pargmann D, Yucel R, Kosan C, Saba I, Klein-Hitpass L, et al. (2007) Differential impact of the transcriptional repressor Gfi1 on mature CD4+ and CD8+ T lymphocyte function. Eur J Immunol 37: 3551-3563.
57. Schmidt T, Karsunky H, Rodel B, Zevnik B, Elsasser HP, et al. (1998) Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection. EMBO J 17: 5349-5359.
58. Taghon TN, David ES, Zuniga-Pflucker JC, Rothenberg EV, (2005) Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev 19: 965-978.
59. Yui MA, Feng N, Rothenberg EV, (2010) Fine-scale staging of T cell lineage commitment in adult mouse thymus. J Immunol 185: 284-293.
60. Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, et al. (2006) NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A 103: 18261-18266.
61. Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, et al. (2006) c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 20: 2096-2109.
62. Sharma VM, Calvo JA, Draheim KM, Cunningham LA, Hermance N, et al. (2006) Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol 26: 8022-8031.
63. Wendorff AA, Koch U, Wunderlich FT, Wirth S, Dubey C, et al. (2010) Hes1 is a critical but context-dependent mediator of canonical Notch signaling in lymphocyte development and transformation. Immunity 33: 671-684.
64. Masiero M, Minuzzo S, Pusceddu I, Moserle L, Persano L, et al. (2011) Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells. Leukemia 25: 588-598.
65. Suliman S, Tan J, Xu K, Kousis PC, Kowalski PE, et al. (2011) Notch3 is dispensable for thymocyte beta-selection and Notch1-induced T cell leukemogenesis. PLoS One 6: e24937.
66. Medyouf H, Gusscott S, Wang H, Tseng JC, Wai C, et al. (2011) High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling. J Exp Med 208: 1809-1822.
67. Weber BN, Chi AW, Chavez A, Yashiro-Ohtani Y, Yang Q, et al. (2011) A critical role for TCF-1 in T-lineage specification and differentiation. Nature 476: 63-68.
68. Germar K, Dose M, Konstantinou T, Zhang J, Wang H, et al. (2011) T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc Natl Acad Sci U S A 108: 20060-20065.
69. Li P, Burke S, Wang J, Chen X, Ortiz M, et al. (2010) Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 329: 85-89.
70. Grimes HL, Gilks CB, Chan TO, Porter S, Tsichlis PN, (1996) The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death. Proc Natl Acad Sci U S A 93: 14569-14573.
71. Zohren F, Souroullas GP, Luo M, Gerdemann U, Imperato MR, et al. (2012) The transcription factor Lyl-1 regulates lymphoid specification and the maintenance of early T lineage progenitors. Nat Immunol 13: 761-769.
72. Spooner CJ, Cheng JX, Pujadas E, Laslo P, Singh H, (2009) A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity 31: 576-586.
73. Franco CB, Scripture-Adams DD, Proekt I, Taghon T, Weiss AH, et al. (2006) Notch/Delta signaling constrains reengineering of pro-T cells by PU.1. Proc Natl Acad Sci U S A 103: 11993-11998.
74. Laslo P, Spooner CJ, Warmflash A, Lancki DW, Lee HJ, et al. (2006) Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 126: 755-766.
75. Doan LL, Kitay MK, Yu Q, Singer A, Herblot S, et al. (2003) Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment. J Immunol 170: 2356-2366.
76. Hock H, Hamblen MJ, Rooke HM, Traver D, Bronson RT, et al. (2003) Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 18: 109-120.